Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1Q35
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $125,422
Award facts
- Contract value 100% obligated
- $125,422.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $125,422.25 to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 mL auto-injector units. This firm fixed-price contract, issued on December 18, 2025, with completion targeted for December 19, 2025, represents a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIMZELX (bimekizumab) is a monoclonal antibody used in the treatment of immunological and inflammatory conditions, and the auto-injector format facilitates patient administration within military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains a comprehensive portfolio supplying medications, vaccines, and specialized medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent IDC enables flexible ordering of pharmaceutical products to support military healthcare programs globally, with this particular delivery order fulfilling immediate supply requirements for specialty biologic medications.
Quick answers
Who was awarded contract SPE2DR26F1Q35?
SPE2DR26F1Q35 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F1Q35 worth?
The government has obligated $125,422 on SPE2DR26F1Q35.
Is contract SPE2DR26F1Q35 an order under another contract?
Yes. SPE2DR26F1Q35 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Q35 competed?
The extent of competition for SPE2DR26F1Q35 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award